Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOGEN INC. Director's Dealing 2013

May 31, 2013

30291_dirs_2013-05-31_42140026-4fce-4859-9f6e-b5f1e28c1180.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOGEN IDEC INC. (BIIB)
CIK: 0000875045
Period of Report: 2013-05-29

Reporting Person: DENNER ALEXANDER J (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-05-29 Common Stock M 3000 $53.43 Acquired 7920 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-05-29 Stock Option (Right to Buy) $53.43 M 3000 Disposed 2019-06-02 Common Stock (3000) Direct

Footnotes

F1: Exercise pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.

F2: Granted under one of the Issuer's stock option plans, in an exempt transaction under SEC Rule 16(b)-3(d).